A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes

被引：0
|
作者：
de Castro, C. [1 ]
Adams, D. [1 ]
Rizzieri, D. [1 ]
Moore, J. [1 ]
Gockerman, J. [1 ]
Diehl, L. [1 ]
Horwitz, M. [1 ]
Edmonds, E. [1 ]
Warzecho, J. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70210-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [21] Trisenox® (arsenic trioxide) in patients with myelodysplastic syndromes (MDS):: Preliminary findings in a phase 2 clinical study.
    List, AF
    Schiller, GJ
    Mason, J
    Douer, D
    Ellison, R
    BLOOD, 2003, 102 (11) : 423A - 423A
  • [22] Decitabine dosage in myelodysplastic syndromes
    Giagounidis, Aristoteles A. N.
    BLOOD, 2007, 110 (03) : 1082 - 1083
  • [23] Decitabine (Dacogen) for myelodysplastic syndromes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1247): : 91 - 92
  • [24] Decitabine in the treatment of myelodysplastic syndromes
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Issa, Jean-Pierre
    Ravandi, Farhad
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (01) : 9 - 22
  • [25] Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes
    Ding, Kai
    Fu, Rong
    Liu, Hui
    Nachnani, Deepak Anil
    Shao, Zong-Hong
    ONCOLOGY LETTERS, 2016, 11 (04) : 2347 - 2352
  • [26] Which myelodysplastic syndromes patients are candidates for treatment with decitabine?
    Luebbert, M.
    LEUKEMIA RESEARCH, 2007, 31 : S20 - S20
  • [27] Arsenic trioxide, ascorbic acid, filgrastim and erythropoietin for the treatment of myelodysplastic syndromes
    Khera, N.
    Miske, H.
    Shadduck, R. K.
    Rossetti, J. M.
    Lister, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] A Phase I Dose-Escalation Study of Combination Decitabine, Arsenic Trioxide and Ascorbic Acid In Patients with MDS and AML.
    Welch, John S.
    Klco, Jeffery
    Gao, Feng
    Hassan, Anjum
    Vij, Ravi
    BLOOD, 2010, 116 (21) : 887 - 888
  • [29] The role of decitabine in the treatment of myelodysplastic syndromes
    Atallah, Ehab
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) : 65 - 73
  • [30] Decitabine treatment of patients with higher-risk myelodysplastic syndromes
    Steensma, David P.
    LEUKEMIA RESEARCH, 2009, 33 : S12 - S17
12345